-
1
-
-
85027940811
-
Neuroendocrine tumors of the pancreas
-
Milan SA, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol 2012; 24:46-55
-
(2012)
Curr Opin Oncol
, vol.24
, pp. 46-55
-
-
Milan, S.A.1
Yeo, C.J.2
-
2
-
-
77954330417
-
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Oberg K, Akerstrom G, Rindi G, Jelic S. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(suppl 5):v223-v227
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
-
-
Oberg, K.1
Akerstrom, G.2
Rindi, G.3
Jelic, S.4
-
3
-
-
83255171192
-
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
-
Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012; 61:6-32
-
(2012)
Gut
, vol.61
, pp. 6-32
-
-
Ramage, J.K.1
Ahmed, A.2
Ardill, J.3
-
5
-
-
6044252534
-
Endocrine tumors of the gut and pancreas tumor biology and classification
-
Rindi G, Kloppel G. Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 2004; 80(suppl 1):12-15
-
(2004)
Neuroendocrinology
, vol.80
, Issue.SUPPL. 1
, pp. 12-15
-
-
Rindi, G.1
Kloppel, G.2
-
6
-
-
82155162338
-
Neuroendocrine neoplasms of the gastroenteropancreatic system: Pathology and classification
-
Anlauf M. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Horm Metab Res 2011; 43:825-831
-
(2011)
Horm Metab Res
, vol.43
, pp. 825-831
-
-
Anlauf, M.1
-
7
-
-
80052218182
-
Extrapulmonary small cell carcinoma: A pictorial review
-
Howard S, O'Regan K, Jagannathan J, Krajewski K, Giardino A, Ramaiya N. Extrapulmonary small cell carcinoma: a pictorial review. AJR 2011; 197:[web]W392-W398
-
(2011)
AJR
, vol.197
-
-
Howard, S.1
O'regan, K.2
Jagannathan, J.3
Krajewski, K.4
Giardino, A.5
Ramaiya, N.6
-
8
-
-
84859417274
-
New strategies for advanced neuroendocrine tumors in the era of targeted therapy
-
Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res 2012; 18:1830-1836
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1830-1836
-
-
Dong, M.1
Phan, A.T.2
Yao, J.C.3
-
9
-
-
84857658992
-
Neuroendocrine pancreatic tumors: Guidelines for management and update
-
Burns WR, Edil BH. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol 2012; 13:24-34
-
(2012)
Curr Treat Options Oncol
, vol.13
, pp. 24-34
-
-
Burns, W.R.1
Edil, B.H.2
-
10
-
-
64249099411
-
-
7th ed. New York, NY: Springer-Verlag
-
Edge SB, Byrd DR, Compton CC, et al., eds. AJCC cancer staging manual, 7th ed. New York, NY: Springer-Verlag, 2010
-
(2010)
AJCC Cancer Staging Manual
-
-
Edge, S.B.1
Byrd, D.R.2
Compton, C.C.3
-
11
-
-
84862135843
-
Neuroendocrine tumors of the digestive tract: Impact of new classifications and new agents on therapeutic approaches
-
Oberg K. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Curr Opin Oncol 2012; 24:433-440
-
(2012)
Curr Opin Oncol
, vol.24
, pp. 433-440
-
-
Oberg, K.1
-
12
-
-
69749113601
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification
-
Klöppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90:162-166
-
(2009)
Neuroendocrinology
, vol.90
, pp. 162-166
-
-
Klöppel, G.1
Couvelard, A.2
Perren, A.3
-
13
-
-
84863924208
-
Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: The UCSF experience with 149 patients
-
Parekh JR, Wang SC, Bergsland EK, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas 2012; 41:840-844
-
(2012)
Pancreas
, vol.41
, pp. 840-844
-
-
Parekh, J.R.1
Wang, S.C.2
Bergsland, E.K.3
-
14
-
-
84879504694
-
Pancreatic neuroendocrine neoplasms: Diagnosis and management
-
Balachandran A, Tamm EP, Bhosale PR, et al. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 2013; 38:342-357
-
(2013)
Abdom Imaging
, vol.38
, pp. 342-357
-
-
Balachandran, A.1
Tamm, E.P.2
Bhosale, P.R.3
-
15
-
-
84855940639
-
The role of somatostatin and dopamine D2 receptors in endocrine tumors
-
Gatto F, Hofland LJ. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr Relat Cancer 2011; 18:R233-R251
-
(2011)
Endocr Relat Cancer
, vol.18
-
-
Gatto, F.1
Hofland, L.J.2
-
16
-
-
84862216823
-
Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors: The key role of cellular differentiation and tumor grade-from theory to clinical practice
-
Rust E, Hubele F, Marzano E, et al. Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors: the key role of cellular differentiation and tumor grade-from theory to clinical practice. Cancer Imaging 2012; 12:173-184
-
(2012)
Cancer Imaging
, vol.12
, pp. 173-184
-
-
Rust, E.1
Hubele, F.2
Marzano, E.3
-
17
-
-
77954556448
-
Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
-
Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16:2963-2970
-
(2010)
World J Gastroenterol
, vol.16
, pp. 2963-2970
-
-
Strosberg, J.1
Kvols, L.2
-
18
-
-
79958182014
-
Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ ileum and pancreatic origin
-
Auernhammer CJ, Goke B. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ ileum and pancreatic origin. Gut 2011; 60:1009-1021
-
(2011)
Gut
, vol.60
, pp. 1009-1021
-
-
Auernhammer, C.J.1
Goke, B.2
-
19
-
-
70350442637
-
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group
-
Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27:4656-4663
-
(2009)
J Clin Oncol
, vol.27
, pp. 4656-4663
-
-
Rinke, A.1
Muller, H.H.2
Schade-Brittinger, C.3
-
20
-
-
55549090724
-
Moertel's land of small tumors
-
Kvols LK, Revisiting C. G. Moertel's land of small tumors. J Clin Oncol 2008; 26:5005-5007
-
(2008)
J Clin Oncol
, vol.26
, pp. 5005-5007
-
-
Kvols, L.K.1
Revisiting, C.G.2
-
21
-
-
78650980295
-
Surgical management of hepatic neuroendocrine tumor metastasis: Results from an international multi-institutional analysis
-
Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol 2010; 17:3129-3136
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 3129-3136
-
-
Mayo, S.C.1
De Jong, M.C.2
Pulitano, C.3
-
22
-
-
69249165991
-
Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation
-
Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 2009; 72:517-528
-
(2009)
Eur J Radiol
, vol.72
, pp. 517-528
-
-
Vogl, T.J.1
Naguib, N.N.2
Zangos, S.3
Eichler, K.4
Hedayati, A.5
Nour-Eldin, N.E.6
-
23
-
-
77950789991
-
Evidence-based imaging of pancreatic malignancies
-
Kinney T. Evidence-based imaging of pancreatic malignancies. Surg Clin North Am 2010; 90:235-249
-
(2010)
Surg Clin North Am
, vol.90
, pp. 235-249
-
-
Kinney, T.1
-
24
-
-
84860573042
-
Imaging of pancreatic adenocarcinoma: Update on staging/resectability
-
Tamm EP, Balachandran A, Bhosale PR, et al. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 2012; 50:407-428
-
(2012)
Radiol Clin North Am
, vol.50
, pp. 407-428
-
-
Tamm, E.P.1
Balachandran, A.2
Bhosale, P.R.3
-
25
-
-
1442305705
-
Carcinoid tumors of the small bowel: A multitechnique imaging approach
-
Horton KM, Kamel I, Hofmann L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR 2004; 182:559-567
-
(2004)
AJR
, vol.182
, pp. 559-567
-
-
Horton, K.M.1
Kamel, I.2
Hofmann, L.3
Fishman, E.K.4
-
26
-
-
84871612736
-
Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: The challenges ahead
-
Sundin A, Rockall A. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology 2012; 96:261-271
-
(2012)
Neuroendocrinology
, vol.96
, pp. 261-271
-
-
Sundin, A.1
Rockall, A.2
-
27
-
-
84859118421
-
Personalized tumor response assessment in the era of molecular medicine: Cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST
-
Nishino M, Jagannathan JP, Krajewski KM, et al. Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. AJR 2012; 198:737-745
-
(2012)
AJR
, vol.198
, pp. 737-745
-
-
Nishino, M.1
Jagannathan, J.P.2
Krajewski, K.M.3
-
28
-
-
84883412076
-
Liver metastases in the era of molecular targeted therapy: New faces of treatment response
-
Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH. Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR 2013; 200:[web]W15-W28
-
(2013)
AJR
, vol.200
-
-
Shinagare, A.B.1
Jagannathan, J.P.2
Krajewski, K.M.3
Ramaiya, N.H.4
-
29
-
-
53149139919
-
Neuroendocrine tumors: Role of interventional radiology in therapy
-
Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, Yu D. Neuroendocrine tumors: role of interventional radiology in therapy. RadioGraphics 2008; 28:1131-1145
-
(2008)
RadioGraphics
, vol.28
, pp. 1131-1145
-
-
Steward, M.J.1
Warbey, V.S.2
Malhotra, A.3
Caplin, M.E.4
Buscombe, J.R.5
Yu, D.6
-
30
-
-
79960321605
-
Assessment of the treatment response of HCC
-
Kim KW, Lee JM, Choi BI. Assessment of the treatment response of HCC. Abdom Imaging 2011; 36:300-314
-
(2011)
Abdom Imaging
, vol.36
, pp. 300-314
-
-
Kim, K.W.1
Lee, J.M.2
Choi, B.I.3
-
31
-
-
0032911782
-
Octreotide stimulates Ca++ secretion by the gallbladder: A risk factor for gallstones
-
Moser AJ, Giurgiu DI, Morgenstern KE, Abedin ZR, Roslyn JJ, Abedin MZ. Octreotide stimulates Ca++ secretion by the gallbladder: a risk factor for gallstones. Surgery 1999; 125:509-513
-
(1999)
Surgery
, vol.125
, pp. 509-513
-
-
Moser, A.J.1
Giurgiu, D.I.2
Morgenstern, K.E.3
Abedin, Z.R.4
Roslyn, J.J.5
Abedin, M.Z.6
-
32
-
-
84871285820
-
What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents
-
Chikarmane SA, Khurana B, Krajewski KM, et al. What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents. Emerg Radiol 2012; 19:535-546
-
(2012)
Emerg Radiol
, vol.19
, pp. 535-546
-
-
Chikarmane, S.A.1
Khurana, B.2
Krajewski, K.M.3
-
33
-
-
84863648475
-
Decade of molecular targeted therapy: Abdominal manifestations of drug toxicities-what radiologists should know
-
Howard SA, Krajewski KM, Thornton E, et al. Decade of molecular targeted therapy: abdominal manifestations of drug toxicities-what radiologists should know. AJR 2012; 199:58-64
-
(2012)
AJR
, vol.199
, pp. 58-64
-
-
Howard, S.A.1
Krajewski, K.M.2
Thornton, E.3
-
34
-
-
84864954263
-
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
-
Albiges L, Chamming's F, Duclos B, et al. Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. Ann Oncol 2012; 23:1943-1953
-
(2012)
Ann Oncol
, vol.23
, pp. 1943-1953
-
-
Albiges, L.1
Chamming's, F.2
Duclos, B.3
-
35
-
-
34249085905
-
Correlation of CT and PET in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new CT response criteria
-
Choi H, Charnsangavej C, Faria SC, et al. Correlation of CT and PET in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new CT response criteria. J Clin Oncol 2007; 25:1753-1759
-
(2007)
J Clin Oncol
, vol.25
, pp. 1753-1759
-
-
Choi, H.1
Charnsangavej, C.2
Faria, S.C.3
-
36
-
-
77349102071
-
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
-
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30:52-60
-
(2010)
Semin Liver Dis
, vol.30
, pp. 52-60
-
-
Lencioni, R.1
Llovet, J.M.2
|